JUBILANT PHARMOVA
Back to Cashflow Statement
|
JUBILANT PHARMOVA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,453 Cr | ₹-433 Cr | ₹-157 Cr | ₹-33 Cr | ₹-1,709 Cr |
What is the latest Cash Flow from Financing Activities ratio of JUBILANT PHARMOVA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1,453 Cr |
| Mar2024 | ₹-433 Cr |
| Mar2023 | ₹-157 Cr |
| Mar2022 | ₹-33 Cr |
| Mar2021 | ₹-1,709 Cr |
How is Cash Flow from Financing Activities of JUBILANT PHARMOVA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,453 Cr | Negative | |
| Mar2024 | ₹-433 Cr | Negative | |
| Mar2023 | ₹-157 Cr | Negative | |
| Mar2022 | ₹-33 Cr | Negative | |
| Mar2021 | ₹-1,709 Cr | - | |
Compare Cash Flow from Financing Activities of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹13,250.6 Cr | 1.1% | -5.3% | -1.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | 1.1% |
-5.3% |
-1.1% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses